SCHEMBL5022369

SCHEMBL5022369

CCOCC1CN(S(=O)(=O)c2cccc(N)c2)c2cc(NC(=O)c3c(F)cccc3Cl)ccc2O1

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RORC P51449 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5022530 0.95 RORC (0.58) RORC
SCHEMBL5022528 0.93 RORC (0.68) RORC
SCHEMBL5021993 0.91 RORC (0.67) RORC
SCHEMBL5022483 0.91 RORC (0.66) RORC
SCHEMBL5022517 0.90 RORC (0.65) RORC
SCHEMBL5022072 0.90 RORC (0.65) RORC
SCHEMBL15625861 0.90 RORC (0.83) RORC
SCHEMBL5021992 0.90 RORC (0.79) RORC
SCHEMBL10280247 0.90 RORC (0.79) RORC
SCHEMBL5022526 0.88 RORC (0.62) RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012064744-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORϒ ACTIVITY AND THE TREATMENT OF DISEASE LYCERA CORPORATION (US) 2012-05-18 WO disclosed